ABUS — ARBUTUS BIOPHARMA CORP

Ownership history in STEMPOINT CAPITAL LP  ·  4 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in ARBUTUS BIOPHARMA CORP (ABUS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.81% (2025 Q4)
Avg. % of fund
0.38%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 986,751 +891,751 +938.7% 0.81% $4.7M $4.81
2025 Q3 REDUCED 95,000 -110,388 -53.7% 0.00% $10K $4.54
2025 Q3 REDUCED 205,388 -262,494 -56.1% 0.19% $932K $4.54
2025 Q1 INITIATED 467,882 — — 0.52% $1.6M $3.49
% of Fund (quarterly)    ABUS price (monthly, adj. close)

Other funds also holding ABUS

As of 2025 Q4 — sorted by position size

Whitefort Capital Management, LP 3Y 16.41% Rangeley Capital, LLC 3.36% ADAR1 Capital Management, LLC 1.89% Two Seas Capital LP 3Y 1.25% Western Standard LLC 3Y 7Y 1.13% BlackBarn Capital Partners LP 0.59% SHERBROOKE PARK ADVISERS LLC 3Y 0.35% AlphaCentric Advisors LLC 3Y 0.23% Murchinson Ltd. 3Y 0.21% Exome Asset Management LLC 0.17%
← Back to STEMPOINT CAPITAL LP Holdings